Future US policy debates regarding the connection between prescription drug rebates and insurance costs will be informed by a transparency requirement tucked into the $900bn economic stimulus and US government funding bill signed into law on 28 December.
Drug Rebates, Impact On Premiums Must Be Disclosed Under COVID Stimulus Law
Medicare Part B payment loopholes also targeted in law, and Medicare Part D plans will need to offer real-time benefit tools for prescriber-patient decision making.
